Larvol Delta - A-study-of-opaganib-in-addition-to-darolutamide-in-participants-with-metastatic-hormone-resistant-prostate-cancer-selected-for-the-presence-of-a-specic-biomarker

Nubeqa (darolutamide) - Bayer, Orion Corp

Yeliva (opaganib) - RedHill

https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12624001458527

Jul 11, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next